Overall, cohort-specific machine-learning models demonstrated stronger discrimination, while the external applicability of the mechanistic framework depended on the alignment of available predictors and clinical endpoints in the target cohort.
Abstract
Cardiovascular risk assessment remains a central challenge in both population-based prevention and high-risk clinical settings. We benchmarked a previously developed mechanistic model of cardiovascular ageing against machine-learning baselines across two distinct cohorts and evaluated both discrimination and probability calibration. The mechanistic model was based on an ordinary differential equation (ODE) framework and adapted to the observable interaction structure of two independent public datasets: the Framingham Heart Study cardiovascular risk dataset, with 10-year coronary heart disease as the outcome, and the Heart Failure Clinical Records dataset, with mortality as the outcome. ElasticNet logistic regression and XGBoost were evaluated as cohort-specific machine-learning benchmarks. Predictive performance was assessed using repeated stratified five-fold cross-validation with three repeats. In the Framingham cohort (n = 4240; 644 events), ElasticNet achieved ROC-AUC = 0.727 (95% CI 0.705–0.747), PR-AUC = 0.343, and Brier score = 0.116, while XGBoost achieved ROC-AUC = 0.715 (95% CI 0.694–0.737), PR-AUC = 0.325, and Brier score = 0.118. The observable mechanistic score showed weaker discrimination, with ROC-AUC = 0.547 and PR-AUC = 0.202. In the Heart Failure cohort (n = 299; 96 deaths), ElasticNet and XGBoost achieved ROC-AUC values of 0.770 and 0.771, respectively, whereas the mechanistic score achieved ROC-AUC = 0.534. Post hoc calibration improved probability scaling of the mechanistic score but did not restore discriminative performance. Overall, cohort-specific machine-learning models demonstrated stronger discrimination, while the external applicability of the mechanistic framework depended on the alignment of available predictors and clinical endpoints in the target cohort.
Findings highlight blood pressure and body size measures as the dominant clinical signals in this dataset, while demonstrating the potential of an explainable machine-learning model based on routinely collected clinical data to support cardiovascular risk stratification and clinical decision-making in hypertensive pati...
C. M. Anyanwu, J. C. Onyianta, Ogechi Gift Onyedi et al.· Nature Journal of Emerging S...· 0 citations
Background Accurate primary-prevention risk stratification for coronary artery disease (CAD) remains challenging. We developed and internally validated a framework integrating clinical variables with a polygenic risk score (PRS). Methods This three-center retrospective cohort included 2,067 adults without baseline CAD....
F. Lei, Xiang-Wen Xi, Zi-He Dang et al.· Frontiers in Cardiovascular...· 0 citations
An explainable hybrid machine learning system for early heart disease prediction and multistage risk categorization that integrates two types of representation learning and utilizes tree-based ensemble methods to produce not only a binary diagnosis but also a multi-class risk classification.
Ronak Jain, Sachin Patel· Natural Resources for Human...· 0 citations
CKMAI is a valid, CKM‑specific index that outperforms universal biological age measures in predicting mortality and high‑risk CKM status and consistently outperformed PhenoAge, KDM, and the cardiometabolic index across all outcomes.
Zheng-Yang Zhu, Ke-Jun Ren, Dong Wang et al.· PLoS Medicine· 0 citations
ImportanceCardiovascular disease remains the leading cause of mortality worldwide. Although machine learning models have demonstrated strong predictive performance, limited attention has been given to uncertainty quantification and gender-specific risk factor identification, which are essential for clinically trustwort...
S. Roy, R. Imran, M. R. Haque et al.· medRxiv· 0 citations
This study developed an AutoML-based CVD risk prediction model with superior discrimination and calibration, providing clinicians a practical tool for risk stratification, and has the potential to reduce CVD burden at the population level.
Si-Min He, Ju-Ping Wang, Le Zhao et al.· International Journal of Car...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.